2015 Articles
Haploinsufficiency of Bcl11b suppresses the progression of ATM-deficient T cell lymphomas
Bcl11b is a transcription factor important for T cell development and also a tumor-suppressor gene that is hemizygously inactivated in ~10 % human T cell acute lymphoblastic leukemia (T-ALL) and several murine T-ALL models, including ATM−/− thymic lymphomas. Here we report that heterozygous loss of Bcl11b (Bcl11b+/−) unexpectedly reduced lethal thymic lymphoma in ATM−/− mice by suppressing lymphoma progression, but not initiation. The suppression was associated with a T cell-mediated immune response in ATM−/−Bcl11b+/− mice, revealing a haploid insufficient function of Bcl11b in immune modulation against lymphoma and offering an explanation for the complex relationship between Bcl11b status with T-ALL prognosis.
Files
- 13045_2015_Article_191.pdf application/pdf 1.87 MB Download File
Also Published In
- Title
- Journal of Hematology & Oncology
- DOI
- https://doi.org/10.1186/s13045-015-0191-8
More About This Work
- Academic Units
- Irving Comprehensive Cancer Center
- Pathology and Cell Biology
- Institute for Cancer Genetics
- Pediatrics
- Published Here
- July 31, 2015